Community post
Patients in India in need of phage therapy used to have to ship their samples internationally for phage susceptibility testing, which was a dealbreaker for even phage-friendly doctors as this was slow and expensive. Now, they can do it locally because of a new partnership between Vitalis Phage Therapy, the Eliava Institute in Georgia, and a major Indian diagnostics company. For about $11 USD, patients in any city in India will be able to find out within a few days whether their samples are susceptible to the Eliava Institute's phage cocktails.
Topics
| Source | Capsid & Tail #99 |
|---|